Prevention and Treatment of Patient Before, During, and After Covid-19 Infection
Status:
Active, not recruiting
Trial end date:
2022-02-27
Target enrollment:
Participant gender:
Summary
AntiCov-220 prevents and treats before, during, and after infection with SARS-Cov-2. The
composition is fractionally extracted from herbs, using flavonoids, isoflavonoids, and
pregnenolone in combination with ascorbic acid as the key compounds in preventing and killing
SARS-CoV-2; increase antibodies and protect cells; supplementing precursors to help the body
strengthen antibodies and reduce the risk of infection; destroy spike protein, toxic protein,
help prevent blood clots causing stroke; restore the physiological function of cells after
virus infection; helps the body to stabilize the amount of cortisol in the blood as well as
stabilize the production of specific antibodies. The composition participates in
anti-inflammatory and cells protecting process, bringing blood cortisol, B-lymphocytes, Cyfra
21-1, WBC, CRP, fever, dyspnea, and other signs of respiratory tract inflammation to a normal
state and normal limit.